Medical Devices: Page 154


  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Merged GTX medical seeks broader footprint in spinal cord stim market

    GTX hopes to start clinical studies of an implantable spinal cord stimulation system during 2021, CEO Sjaak Decker told MedTech Dive.

    By Dana Elfin • Updated Oct. 22, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Canon gets FDA nod for AI tech to enhance CT images

    Rising use of CT scans, which expose patients to far more radiation than X-rays, has intensified focus on the risks of the imaging technique, particularly in the pediatric population. 

    By Oct. 22, 2019
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Sleep apnea testing shifts to the home, survey suggests

    Use of home-based testing has more than doubled in the past five years as more sleep centers offer the option, which analysts expect will benefit ResMed.

    By Oct. 21, 2019
  • Smith & Nephew taps new CEO with diagnostics, orthopaedics resume

    Namal Nawana led the medtech for just 18 months, but reportedly clashed with the board over pay. Smith & Nephew's stock was down nearly 10% Monday.

    By Dana Elfin • Oct. 21, 2019
  • TAVR vet in at Medtronic diabetes unit amid shakeup

    Cardiac and Vascular Group veteran Sean Salmon will step in to lead Medtronic Diabetes, which has faced an uptick in market competition from CGM makers Abbott and Dexcom and insulin pump manufacturers Tandem and Insulet.

    By Maria Rachal • Oct. 21, 2019
  • Doctor hit with guilty verdict for reusing contaminated catheters, defrauding Medicare

    A California physician submitted approximately $12 million worth of claims to Medicare for the medically unnecessary procedures, pocketing $4.5 million.

    By Dana Elfin • Oct. 18, 2019
  • Leasing da Vinci systems is in style: Intuitive Q3 tops estimates

    The results come as potential competitors Transenterix and Titan Medical stumbled in the past week and Medtronic inches forward with its own robotic surgery platform.

    By Maria Rachal • Oct. 18, 2019
  • Sens. Warren, Cassidy press FDA on difference between servicing and remanufacturing

    The agency does not require servicers, who face fewer regulatory requirements than remanufacturers, to register ​with FDA.

    By David Lim • Oct. 18, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AdvaMed lobbies Trump to repeal medical device tax (again)

    The trade organization has successfully delayed the levy for years, but the latest moratorium expires at year's end.

    By Oct. 18, 2019
  • TransEnterix seeks 'strategic alternatives' amid robot slump, restructuring

    RBC analysts said a sale of the company is the most likely outcome after the medtech engaged J.P. Morgan to explore its options. The company's CFO will depart at the end of the year.  

    By Oct. 18, 2019
  • Researchers question safety benefit of robotic colectomies

    Despite a sharp rise in robot-assisted colon removal procedures using devices like Intuitive Surgical's da Vinci system, research published in JAMA Surgery found a laparoscopic approach has a comparable rate of complications. 

    By Oct. 17, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Key committee pitches adding UDIs to payer claim forms, called 'huge step'

    If a unique device identifier is captured when a high-risk product is implanted, providers will be able to detect complications more quickly, Joe Drozda, the director of outcomes research at Mercy Health, told MedTech Dive.

    By David Lim • Oct. 17, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    FDA grants breakthrough status to next-generation PSA test

    Cleveland Diagnostics' test aims to reduce the number of patients undergoing unnecessary biopsies by looking at structural changes to the protein tied to cancer mutations.

    By Oct. 17, 2019
  • Abbott 'working through a handful of items' with FDA on FreeStyle Libre 2

    Third-quarter revenue for the medtech came in at $8.08 billion, slightly below Wall Street expectations, but executives praised the growth of key products FreeStyle Libre, MitraClip and Alinity on its earnings call.

    By David Lim • Oct. 16, 2019
  • FDA warns dental X-ray supplier over radiation exposure reporting

    The agency said Denterprise International didn't report complaints involving patients accidentally exposed to radiation and asked for a retrospective review of all such incidents.

    By Oct. 16, 2019
  • CMR launches robot, CEO says European deals coming soon

    On the back of a $240 million private financing round, the U.K. medtech is beginning commercial expansion of its modular robotic surgery system in Europe and Asia as it awaits FDA's go-ahead.

    By Maria Rachal • Oct. 16, 2019
  • ViewRay bucks payment fears in field dubbed 'not dead' yet

    The radiation oncology company received eight new orders for its MRI-guided Linac, easily beating Jefferies' forecast. 

    By Oct. 16, 2019
  • Titan scraps filing plan for robotic surgical system amid cash crunch

    The Canadian medtech is abandoning plans to seek FDA clearance to sell its single port system before 2021.

    By Oct. 16, 2019
  • J&J device business outperforms in China as US pricing pressures persist

    Double-digit sales growth in China and a surge in contact lens purchases in Japan helped offset share declines in certain U.S. orthopaedics markets.

    By Maria Rachal • Oct. 15, 2019
  • California bill to end excessive dialysis profits becomes law

    Fresenius said it's concerned the new law will result in patients only being able to access care at hospitals due to lack of insurance coverage. 

    By Oct. 15, 2019
  • Two weeks from Brexit deadline, UK floats device contingency

    A no-deal Brexit would not meet any of MedTech Europe's four priorities. 

    By Oct. 15, 2019
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Hospitals, manufacturers could donate cybersecurity software under proposed regs

    With the cost of protecting systems from malicious hackers increasing, the idea to tweak the anti-kickback laws recognizes some physician practices don't have the resources or expertise to keep pace, one lawyer told MedTech Dive.

    By David Lim • Oct. 14, 2019
  • Image attribution tooltip
    Pixabay
    Image attribution tooltip

    Medical software makers get new guidance on MDR, IVDR

    The European Commission's Medical Device Coordination Group aims to clarify which software will be subject to the new regulations, and how those products should be classified and placed on the market.

    By Dana Elfin • Oct. 14, 2019
  • Abbott deepens Type 2 diabetes play with Omada partnership

    While CGMs have been most widely adopted among the Type 1 population, Abbott has worked to show the technology's benefit in the under-penetrated Type 2 market, which accounts for 95% of all Americans living with diabetes.​

    By Maria Rachal • Oct. 14, 2019
  • FDA pushes back against criticism of third party 510(k) review

    The agency deflected suggestions that the plan puts the burden on patients and doctors to figure out which devices are safe.

    By Oct. 14, 2019